Table 3.

Summary of the reports of extrapyramidal symptoms.

	Number of participants experiencing symptoms at week 4 and week 8*			Cumulative number of participants experiencing symptoms during the study†
Extrapyramidal symptom	Baseline (N = 96)	Week 4 (N = 63)	Week 8 (N = 55)	Weeks 1–4 after baseline	Weeks 1–8 after baseline
Akathisia	3 (3.1%)	4 (6.4%)	1 (1.8%)	13	13
Mild	2	3	1	10	10
Moderate	1	1	0	3	3
Hypokinesia				2	2
Mild	0	0	0	1	1
Moderate				1	1
Rigidity	2 (2.1%)	11 (17.5%)	11 (20%)	31	34
Mild	2	8	10	24	26
Moderate	0	3	1	7	8
Tremor	3 (3.1%)	2 (3.2%)	5 (9.1%)	15	18
Mild	2	2	5	15	16
Moderate	1	0	0	0	2
Acute dystonia
Mild	0	0	0	0	0
Moderate
Dyskinesia					1
Mild	0	0	0	0	1
Moderate					0

*Extrapyramidal symptoms could be reported as mild, moderate, or severe; there were no reports of a severe reaction.

^†Patients who experienced symptoms at least once during the study period.